PubMed:10362839
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-143 | Sentence | denotes | Identification and characterization of a novel UDP-GalNAc:GlcAbeta-R alpha1,4-N-acetylgalactosaminyltransferase from a human sarcoma cell line. |
| TextSentencer_T2 | 144-257 | Sentence | denotes | We recently discovered a novel alpha-N-acetylgalactosaminyltransferase in fetal bovine serum (Kitagawa et al., J. |
| TextSentencer_T3 | 258-263 | Sentence | denotes | Biol. |
| TextSentencer_T4 | 264-556 | Sentence | denotes | Chem., 270, 22190-22195, 1995) and also in mouse mast cytoma cells (Lidholt et al., Glycoconjugate J., 14, 737-742, 1997), which catalyzed the transfer of an alpha-GalNAc residue to the linkage tetrasaccharide-serine, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, derived from proteoglycans. |
| TextSentencer_T5 | 557-762 | Sentence | denotes | In this study, we characterized this enzyme using a preparation obtained from the serum-free culture medium of a human sarcoma (malignant fibrous histiocytoma) cell line by phenyl-Sepharose chromatography. |
| TextSentencer_T6 | 763-1043 | Sentence | denotes | Structural characterization by1H NMR spectroscopy of the reaction product using the linkage tetrasaccharide-serine, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, as a substrate demonstrated that the enzyme was a UDP-GalNAc:GlcAbeta1-R alpha1,4-N -acetylgalactosaminyltransferase. |
| TextSentencer_T7 | 1044-1126 | Sentence | denotes | This is the first identification of an alpha1,4-N-acetylgalactosaminyltransferase. |
| TextSentencer_T8 | 1127-1478 | Sentence | denotes | Using N -acetylchondrosine GlcAbeta1-3GalNAc as an alternative substrate, the enzyme required divalent cations for the transferase reaction, with maximal activity at 20 mM Mn2+and exhibited a dual optimum at pH 6.5 and pH 7.4 depending upon the buffers used, with the highest activity in a 50 mM 2-( N -morpholino)ethanesulfonic acid buffer at pH 6.5. |
| TextSentencer_T9 | 1479-1646 | Sentence | denotes | The apparent Km values obtained for N -acetylchondrosine, the linkage tetrasaccharide-serine, and UDP-GalNAc were 1060 microM, 188 microM, and 27 microM, respectively. |
| TextSentencer_T10 | 1647-1747 | Sentence | denotes | This suggested that the linkage tetrasaccharide-serine was a good acceptor substrate for the enzyme. |
| TextSentencer_T11 | 1748-2021 | Sentence | denotes | In addition, the enzyme utilized glucuronylneolactotetraosylceramide GlcAbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4G lcbeta1-1Cer but not sulfoglucuronylneolactotetraosylceramide GlcA(3-O -sulfate)beta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Gl cbeta1-1Cer as acceptor substrates. |
| TextSentencer_T12 | 2022-2171 | Sentence | denotes | The possibility of involvement of this enzyme in the biosynthesis of glycosaminoglycan as well as other GlcA-containing glycoconjugates is discussed. |
| T1 | 0-143 | Sentence | denotes | Identification and characterization of a novel UDP-GalNAc:GlcAbeta-R alpha1,4-N-acetylgalactosaminyltransferase from a human sarcoma cell line. |
| T2 | 144-556 | Sentence | denotes | We recently discovered a novel alpha-N-acetylgalactosaminyltransferase in fetal bovine serum (Kitagawa et al., J. Biol. Chem., 270, 22190-22195, 1995) and also in mouse mast cytoma cells (Lidholt et al., Glycoconjugate J., 14, 737-742, 1997), which catalyzed the transfer of an alpha-GalNAc residue to the linkage tetrasaccharide-serine, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, derived from proteoglycans. |
| T3 | 557-762 | Sentence | denotes | In this study, we characterized this enzyme using a preparation obtained from the serum-free culture medium of a human sarcoma (malignant fibrous histiocytoma) cell line by phenyl-Sepharose chromatography. |
| T4 | 763-1043 | Sentence | denotes | Structural characterization by1H NMR spectroscopy of the reaction product using the linkage tetrasaccharide-serine, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, as a substrate demonstrated that the enzyme was a UDP-GalNAc:GlcAbeta1-R alpha1,4-N -acetylgalactosaminyltransferase. |
| T5 | 1044-1126 | Sentence | denotes | This is the first identification of an alpha1,4-N-acetylgalactosaminyltransferase. |
| T6 | 1127-1478 | Sentence | denotes | Using N -acetylchondrosine GlcAbeta1-3GalNAc as an alternative substrate, the enzyme required divalent cations for the transferase reaction, with maximal activity at 20 mM Mn2+and exhibited a dual optimum at pH 6.5 and pH 7.4 depending upon the buffers used, with the highest activity in a 50 mM 2-( N -morpholino)ethanesulfonic acid buffer at pH 6.5. |
| T7 | 1479-1646 | Sentence | denotes | The apparent Km values obtained for N -acetylchondrosine, the linkage tetrasaccharide-serine, and UDP-GalNAc were 1060 microM, 188 microM, and 27 microM, respectively. |
| T8 | 1647-1747 | Sentence | denotes | This suggested that the linkage tetrasaccharide-serine was a good acceptor substrate for the enzyme. |
| T9 | 1748-2021 | Sentence | denotes | In addition, the enzyme utilized glucuronylneolactotetraosylceramide GlcAbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4G lcbeta1-1Cer but not sulfoglucuronylneolactotetraosylceramide GlcA(3-O -sulfate)beta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Gl cbeta1-1Cer as acceptor substrates. |
| T10 | 2022-2171 | Sentence | denotes | The possibility of involvement of this enzyme in the biosynthesis of glycosaminoglycan as well as other GlcA-containing glycoconjugates is discussed. |
| T1 | 0-143 | Sentence | denotes | Identification and characterization of a novel UDP-GalNAc:GlcAbeta-R alpha1,4-N-acetylgalactosaminyltransferase from a human sarcoma cell line. |
| T2 | 144-257 | Sentence | denotes | We recently discovered a novel alpha-N-acetylgalactosaminyltransferase in fetal bovine serum (Kitagawa et al., J. |
| T3 | 258-263 | Sentence | denotes | Biol. |
| T4 | 264-556 | Sentence | denotes | Chem., 270, 22190-22195, 1995) and also in mouse mast cytoma cells (Lidholt et al., Glycoconjugate J., 14, 737-742, 1997), which catalyzed the transfer of an alpha-GalNAc residue to the linkage tetrasaccharide-serine, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, derived from proteoglycans. |
| T5 | 557-762 | Sentence | denotes | In this study, we characterized this enzyme using a preparation obtained from the serum-free culture medium of a human sarcoma (malignant fibrous histiocytoma) cell line by phenyl-Sepharose chromatography. |
| T6 | 763-1043 | Sentence | denotes | Structural characterization by1H NMR spectroscopy of the reaction product using the linkage tetrasaccharide-serine, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, as a substrate demonstrated that the enzyme was a UDP-GalNAc:GlcAbeta1-R alpha1,4-N -acetylgalactosaminyltransferase. |
| T7 | 1044-1126 | Sentence | denotes | This is the first identification of an alpha1,4-N-acetylgalactosaminyltransferase. |
| T8 | 1127-1478 | Sentence | denotes | Using N -acetylchondrosine GlcAbeta1-3GalNAc as an alternative substrate, the enzyme required divalent cations for the transferase reaction, with maximal activity at 20 mM Mn2+and exhibited a dual optimum at pH 6.5 and pH 7.4 depending upon the buffers used, with the highest activity in a 50 mM 2-( N -morpholino)ethanesulfonic acid buffer at pH 6.5. |
| T9 | 1479-1646 | Sentence | denotes | The apparent Km values obtained for N -acetylchondrosine, the linkage tetrasaccharide-serine, and UDP-GalNAc were 1060 microM, 188 microM, and 27 microM, respectively. |
| T10 | 1647-1747 | Sentence | denotes | This suggested that the linkage tetrasaccharide-serine was a good acceptor substrate for the enzyme. |
| T11 | 1748-2021 | Sentence | denotes | In addition, the enzyme utilized glucuronylneolactotetraosylceramide GlcAbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4G lcbeta1-1Cer but not sulfoglucuronylneolactotetraosylceramide GlcA(3-O -sulfate)beta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Gl cbeta1-1Cer as acceptor substrates. |
| T12 | 2022-2171 | Sentence | denotes | The possibility of involvement of this enzyme in the biosynthesis of glycosaminoglycan as well as other GlcA-containing glycoconjugates is discussed. |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 231-236 | FMAID:167330 | denotes | serum |
| _T2 | 313-330 | FMAID:66784 | denotes | mast cytoma cells |
| _T3 | 313-330 | FMAID:164938 | denotes | mast cytoma cells |
| _T4 | 325-330 | FMAID:68646 | denotes | cells |
| _T5 | 325-330 | FMAID:169002 | denotes | cells |
| _T6 | 348-362 | FMAID:82782 | denotes | Glycoconjugate |
| _T7 | 348-362 | FMAID:196776 | denotes | Glycoconjugate |
| _T8 | 474-480 | FMAID:196753 | denotes | serine |
| _T9 | 474-480 | FMAID:165609 | denotes | serine |
| _T10 | 474-480 | FMAID:67710 | denotes | serine |
| _T11 | 474-480 | FMAID:82764 | denotes | serine |
| _T12 | 542-555 | FMAID:63015 | denotes | proteoglycans |
| _T13 | 542-555 | FMAID:167397 | denotes | proteoglycans |
| _T14 | 639-644 | FMAID:167330 | denotes | serum |
| _T15 | 871-877 | FMAID:67710 | denotes | serine |
| _T16 | 871-877 | FMAID:165609 | denotes | serine |
| _T17 | 871-877 | FMAID:196753 | denotes | serine |
| _T18 | 871-877 | FMAID:82764 | denotes | serine |
| _T19 | 1565-1571 | FMAID:67710 | denotes | serine |
| _T20 | 1565-1571 | FMAID:82764 | denotes | serine |
| _T21 | 1565-1571 | FMAID:196753 | denotes | serine |
| _T22 | 1565-1571 | FMAID:165609 | denotes | serine |
| _T23 | 1598-1604 | FMAID:165145 | denotes | microM |
| _T24 | 1610-1616 | FMAID:165145 | denotes | microM |
| _T25 | 1625-1631 | FMAID:165145 | denotes | microM |
| _T26 | 1695-1701 | FMAID:82764 | denotes | serine |
| _T27 | 1695-1701 | FMAID:67710 | denotes | serine |
| _T28 | 1695-1701 | FMAID:165609 | denotes | serine |
| _T29 | 1695-1701 | FMAID:196753 | denotes | serine |
| _T30 | 2091-2108 | FMAID:167395 | denotes | glycosaminoglycan |
| _T31 | 2091-2108 | FMAID:63011 | denotes | glycosaminoglycan |
| _T32 | 2142-2157 | FMAID:82782 | denotes | glycoconjugates |
| _T33 | 2142-2157 | FMAID:196776 | denotes | glycoconjugates |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1246-1257 | http://www.uniprot.org/uniprot/Q99484 | denotes | transferase |
uniprot-mouse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1246-1257 | http://www.uniprot.org/uniprot/P38649 | denotes | transferase |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 125-132 | http://purl.bioontology.org/ontology/NCBITAXON/47206 | denotes | sarcoma |
| T2 | 325-330 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T3 | 676-683 | http://purl.bioontology.org/ontology/NCBITAXON/47206 | denotes | sarcoma |
| T4 | 1221-1229 | http://purl.bioontology.org/ontology/NCBITAXON/433098 | denotes | divalent |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 247-249 | http://purl.obolibrary.org/obo/GO_0004306 | denotes | et |
| T2 | 340-342 | http://purl.obolibrary.org/obo/GO_0004306 | denotes | et |
| T3 | 1925-1929 | http://purl.obolibrary.org/obo/GO_0043879 | denotes | GlcA |
| T4 | 2126-2130 | http://purl.obolibrary.org/obo/GO_0043879 | denotes | GlcA |
| T5 | 1935-1942 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
| T6 | 2075-2087 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | biosynthesis |
| T7 | 2075-2108 | http://purl.obolibrary.org/obo/GO_0006024 | denotes | biosynthesis of glycosaminoglycan |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 133-137 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T2 | 325-330 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T3 | 524-527 | http://purl.obolibrary.org/obo/GO_0005790 | denotes | Ser |
| T4 | 921-924 | http://purl.obolibrary.org/obo/GO_0005790 | denotes | Ser |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 231-236 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| T2 | 639-644 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
EDAM-topics
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 119-124 | http://edamontology.org/topic_2815 | denotes | human |
| T2 | 450-457 | http://edamontology.org/topic_0102 | denotes | linkage |
| T3 | 565-570 | http://edamontology.org/topic_3678 | denotes | study |
| T4 | 670-675 | http://edamontology.org/topic_2815 | denotes | human |
| T5 | 796-799 | http://edamontology.org/topic_0593 | denotes | NMR |
| T6 | 796-812 | http://edamontology.org/topic_0593 | denotes | NMR spectroscopy |
| T7 | 800-812 | http://edamontology.org/topic_0593 | denotes | spectroscopy |
| T8 | 847-854 | http://edamontology.org/topic_0102 | denotes | linkage |
| T9 | 1541-1548 | http://edamontology.org/topic_0102 | denotes | linkage |
| T10 | 1671-1678 | http://edamontology.org/topic_0102 | denotes | linkage |
EDAM-DFO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 435-442 | http://edamontology.org/data_1756 | denotes | residue |
| T2 | 763-773 | http://edamontology.org/data_0883 | denotes | Structural |
| T3 | 941-953 | http://edamontology.org/operation_2246 | denotes | demonstrated |
| T4 | 1335-1337 | http://edamontology.org/format_1997 | denotes | pH |
| T5 | 1346-1348 | http://edamontology.org/format_1997 | denotes | pH |
| T6 | 1471-1473 | http://edamontology.org/format_1997 | denotes | pH |
| T7 | 1492-1494 | http://edamontology.org/data_0910 | denotes | Km |
Lectin
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| Lectin_T1 | 250-252 | https://acgg.asia/db/lfdb/LfDB0344 | denotes | al |
| Lectin_T2 | 343-345 | https://acgg.asia/db/lfdb/LfDB0344 | denotes | al |
GlyTouCan-IUPAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| GlycanIUPAC_T1 | 428-434 | "http://rdf.glycoinfo.org/glycan/G23425WZ" | denotes | GalNAc |
| GlycanIUPAC_T2 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G23425WZ" | denotes | GalNAc |
| GlycanIUPAC_T3 | 428-434 | "http://rdf.glycoinfo.org/glycan/G02874VH" | denotes | GalNAc |
| GlycanIUPAC_T4 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G02874VH" | denotes | GalNAc |
| GlycanIUPAC_T5 | 428-434 | "http://rdf.glycoinfo.org/glycan/G99699DW" | denotes | GalNAc |
| GlycanIUPAC_T6 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G99699DW" | denotes | GalNAc |
| GlycanIUPAC_T7 | 428-434 | "http://rdf.glycoinfo.org/glycan/G22074RM" | denotes | GalNAc |
| GlycanIUPAC_T8 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G22074RM" | denotes | GalNAc |
| GlycanIUPAC_T9 | 428-434 | "http://rdf.glycoinfo.org/glycan/G48535VZ" | denotes | GalNAc |
| GlycanIUPAC_T10 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G48535VZ" | denotes | GalNAc |
| GlycanIUPAC_T11 | 428-434 | "http://rdf.glycoinfo.org/glycan/G39738WL" | denotes | GalNAc |
| GlycanIUPAC_T12 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G39738WL" | denotes | GalNAc |
| GlycanIUPAC_T13 | 428-434 | "http://rdf.glycoinfo.org/glycan/G42313WU" | denotes | GalNAc |
| GlycanIUPAC_T14 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G42313WU" | denotes | GalNAc |
| GlycanIUPAC_T15 | 428-434 | "http://rdf.glycoinfo.org/glycan/G00393CK" | denotes | GalNAc |
| GlycanIUPAC_T16 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G00393CK" | denotes | GalNAc |
| GlycanIUPAC_T17 | 428-434 | "http://rdf.glycoinfo.org/glycan/G42649EX" | denotes | GalNAc |
| GlycanIUPAC_T18 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G42649EX" | denotes | GalNAc |
| GlycanIUPAC_T19 | 428-434 | "http://rdf.glycoinfo.org/glycan/G46880SB" | denotes | GalNAc |
| GlycanIUPAC_T20 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G46880SB" | denotes | GalNAc |
| GlycanIUPAC_T21 | 428-434 | "http://rdf.glycoinfo.org/glycan/G75599IR" | denotes | GalNAc |
| GlycanIUPAC_T22 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G75599IR" | denotes | GalNAc |
| GlycanIUPAC_T23 | 428-434 | "http://rdf.glycoinfo.org/glycan/G58985MU" | denotes | GalNAc |
| GlycanIUPAC_T24 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G58985MU" | denotes | GalNAc |
| GlycanIUPAC_T25 | 428-434 | "http://rdf.glycoinfo.org/glycan/G92517PO" | denotes | GalNAc |
| GlycanIUPAC_T26 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G92517PO" | denotes | GalNAc |
| GlycanIUPAC_T27 | 428-434 | "http://rdf.glycoinfo.org/glycan/G88512YL" | denotes | GalNAc |
| GlycanIUPAC_T28 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G88512YL" | denotes | GalNAc |
| GlycanIUPAC_T29 | 428-434 | "http://rdf.glycoinfo.org/glycan/G41473NX" | denotes | GalNAc |
| GlycanIUPAC_T30 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G41473NX" | denotes | GalNAc |
| GlycanIUPAC_T31 | 428-434 | "http://rdf.glycoinfo.org/glycan/G71089RB" | denotes | GalNAc |
| GlycanIUPAC_T32 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G71089RB" | denotes | GalNAc |
| GlycanIUPAC_T33 | 428-434 | "http://rdf.glycoinfo.org/glycan/G73485GZ" | denotes | GalNAc |
| GlycanIUPAC_T34 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G73485GZ" | denotes | GalNAc |
| GlycanIUPAC_T35 | 428-434 | "http://rdf.glycoinfo.org/glycan/G61406KC" | denotes | GalNAc |
| GlycanIUPAC_T36 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G61406KC" | denotes | GalNAc |
| GlycanIUPAC_T37 | 428-434 | "http://rdf.glycoinfo.org/glycan/G34412GZ" | denotes | GalNAc |
| GlycanIUPAC_T38 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G34412GZ" | denotes | GalNAc |
| GlycanIUPAC_T39 | 428-434 | "http://rdf.glycoinfo.org/glycan/G67209FP" | denotes | GalNAc |
| GlycanIUPAC_T40 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G67209FP" | denotes | GalNAc |
| GlycanIUPAC_T41 | 428-434 | "http://rdf.glycoinfo.org/glycan/G61442IL" | denotes | GalNAc |
| GlycanIUPAC_T42 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G61442IL" | denotes | GalNAc |
| GlycanIUPAC_T43 | 428-434 | "http://rdf.glycoinfo.org/glycan/G93729MV" | denotes | GalNAc |
| GlycanIUPAC_T44 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G93729MV" | denotes | GalNAc |
| GlycanIUPAC_T45 | 428-434 | "http://rdf.glycoinfo.org/glycan/G92144AE" | denotes | GalNAc |
| GlycanIUPAC_T46 | 1581-1587 | "http://rdf.glycoinfo.org/glycan/G92144AE" | denotes | GalNAc |
| GlycanIUPAC_T47 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G91489RT" | denotes | GlcA |
| GlycanIUPAC_T48 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G91489RT" | denotes | GlcA |
| GlycanIUPAC_T49 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G54004DL" | denotes | GlcA |
| GlycanIUPAC_T50 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G54004DL" | denotes | GlcA |
| GlycanIUPAC_T51 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G90208ZS" | denotes | GlcA |
| GlycanIUPAC_T52 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G90208ZS" | denotes | GlcA |
| GlycanIUPAC_T53 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G47973RQ" | denotes | GlcA |
| GlycanIUPAC_T54 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G47973RQ" | denotes | GlcA |
| GlycanIUPAC_T55 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G35471RR" | denotes | GlcA |
| GlycanIUPAC_T56 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G35471RR" | denotes | GlcA |
| GlycanIUPAC_T57 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G45399NV" | denotes | GlcA |
| GlycanIUPAC_T58 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G45399NV" | denotes | GlcA |
| GlycanIUPAC_T59 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G52061FU" | denotes | GlcA |
| GlycanIUPAC_T60 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G52061FU" | denotes | GlcA |
| GlycanIUPAC_T61 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G10736YH" | denotes | GlcA |
| GlycanIUPAC_T62 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G10736YH" | denotes | GlcA |
| GlycanIUPAC_T63 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G30254CI" | denotes | GlcA |
| GlycanIUPAC_T64 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G30254CI" | denotes | GlcA |
| GlycanIUPAC_T65 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G57856MN" | denotes | GlcA |
| GlycanIUPAC_T66 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G57856MN" | denotes | GlcA |
| GlycanIUPAC_T67 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G95754KF" | denotes | GlcA |
| GlycanIUPAC_T68 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G95754KF" | denotes | GlcA |
| GlycanIUPAC_T69 | 1925-1929 | "http://rdf.glycoinfo.org/glycan/G90067UQ" | denotes | GlcA |
| GlycanIUPAC_T70 | 2126-2130 | "http://rdf.glycoinfo.org/glycan/G90067UQ" | denotes | GlcA |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 231-236 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| PD-UBERON-AE-B_T2 | 639-644 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 676-683 | HP_0100242 | denotes | sarcoma |
| T2 | 703-715 | HP_0012315 | denotes | histiocytoma |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 125-132 | Phenotype | denotes | sarcoma | HP:0100242 |
| T2 | 676-683 | Phenotype | denotes | sarcoma | HP:0100242 |
| T3 | 703-715 | Phenotype | denotes | histiocytoma | HP:0012315 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 125-132 | Disease | denotes | sarcoma | http://purl.obolibrary.org/obo/MONDO_0005089 |
| T2 | 676-683 | Disease | denotes | sarcoma | http://purl.obolibrary.org/obo/MONDO_0005089 |
| T3 | 685-715 | Disease | denotes | malignant fibrous histiocytoma | http://purl.obolibrary.org/obo/MONDO_0002142 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T3 | 703-715 | Phenotype | denotes | histiocytoma | HP:0012315 |
| T1 | 125-132 | Phenotype | denotes | sarcoma | HP:0100242 |
| T2 | 676-683 | Phenotype | denotes | sarcoma | HP:0100242 |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 428-434 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
| T2 | 1581-1587 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
| T3 | 51-57 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
| T5 | 980-986 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 428-434 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
| T2 | 1581-1587 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 119-124 | Organism | denotes | human | 9606 |
| T2 | 224-230 | Organism | denotes | bovine | 9913 |
| T3 | 307-312 | Organism | denotes | mouse | 10088|10090 |
| T5 | 670-675 | Organism | denotes | human | 9606 |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 125-132 | Disease | denotes | sarcoma | MONDO:0005089 |
| T2 | 676-683 | Disease | denotes | sarcoma | MONDO:0005089 |
| T3 | 685-715 | Disease | denotes | malignant fibrous histiocytoma | MONDO:0002142 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-143 | Sentence | denotes | Identification and characterization of a novel UDP-GalNAc:GlcAbeta-R alpha1,4-N-acetylgalactosaminyltransferase from a human sarcoma cell line. |
| T2 | 144-556 | Sentence | denotes | We recently discovered a novel alpha-N-acetylgalactosaminyltransferase in fetal bovine serum (Kitagawa et al., J. Biol. Chem., 270, 22190-22195, 1995) and also in mouse mast cytoma cells (Lidholt et al., Glycoconjugate J., 14, 737-742, 1997), which catalyzed the transfer of an alpha-GalNAc residue to the linkage tetrasaccharide-serine, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, derived from proteoglycans. |
| T3 | 557-762 | Sentence | denotes | In this study, we characterized this enzyme using a preparation obtained from the serum-free culture medium of a human sarcoma (malignant fibrous histiocytoma) cell line by phenyl-Sepharose chromatography. |
| T4 | 763-1043 | Sentence | denotes | Structural characterization by1H NMR spectroscopy of the reaction product using the linkage tetrasaccharide-serine, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, as a substrate demonstrated that the enzyme was a UDP-GalNAc:GlcAbeta1-R alpha1,4-N -acetylgalactosaminyltransferase. |
| T5 | 1044-1126 | Sentence | denotes | This is the first identification of an alpha1,4-N-acetylgalactosaminyltransferase. |
| T6 | 1127-1478 | Sentence | denotes | Using N -acetylchondrosine GlcAbeta1-3GalNAc as an alternative substrate, the enzyme required divalent cations for the transferase reaction, with maximal activity at 20 mM Mn2+and exhibited a dual optimum at pH 6.5 and pH 7.4 depending upon the buffers used, with the highest activity in a 50 mM 2-( N -morpholino)ethanesulfonic acid buffer at pH 6.5. |
| T7 | 1479-1646 | Sentence | denotes | The apparent Km values obtained for N -acetylchondrosine, the linkage tetrasaccharide-serine, and UDP-GalNAc were 1060 microM, 188 microM, and 27 microM, respectively. |
| T8 | 1647-1747 | Sentence | denotes | This suggested that the linkage tetrasaccharide-serine was a good acceptor substrate for the enzyme. |
| T9 | 1748-2021 | Sentence | denotes | In addition, the enzyme utilized glucuronylneolactotetraosylceramide GlcAbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4G lcbeta1-1Cer but not sulfoglucuronylneolactotetraosylceramide GlcA(3-O -sulfate)beta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Gl cbeta1-1Cer as acceptor substrates. |
| T10 | 2022-2171 | Sentence | denotes | The possibility of involvement of this enzyme in the biosynthesis of glycosaminoglycan as well as other GlcA-containing glycoconjugates is discussed. |
GlyCosmos15-FMA
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 231-236 | Body_part | denotes | serum | FMA:63083 |
| T2 | 639-644 | Body_part | denotes | serum | FMA:63083 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 119-124 | OrganismTaxon | denotes | human | 9606 |
| T2 | 224-230 | OrganismTaxon | denotes | bovine | 9913 |
| T3 | 307-312 | OrganismTaxon | denotes | mouse | 10088|10090 |
| T5 | 670-675 | OrganismTaxon | denotes | human | 9606 |